Dr. Robert Carey, M.D.
What this data tells you about Dr. Carey
Dr. Robert Carey is an urology physician in Sarasota, FL, with 20 years in practice. Based on federal Medicare data, Dr. Carey performed 41,451 Medicare services across 4,625 unique beneficiaries.
Between the years covered by Open Payments, Dr. Carey received a total of $16,898 from 55 pharmaceutical and/or device companies across 292 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Carey is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, degarelix, 1 mg | 19,923 | $3 | $8 |
| Botox injection, per unit | 9,502 | $5 | $10 |
| BCG treatment for bladder cancer | 3,302 | $2 | $6 |
| Denosumab injection (Prolia/Xgeva) | 2,340 | $18 | $31 |
| Office visit, established patient (30-39 min) | 1,647 | $88 | $219 |
| Automated urinalysis | 1,084 | $2 | $6 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 460 | $134 | $550 |
| Office visit, established patient (20-29 min) | 450 | $66 | $151 |
| Diagnostic exam of bladder and urethra using an endoscope | 431 | $170 | $454 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 303 | $24 | $67 |
| New patient office visit (45-59 min) | 211 | $113 | $333 |
| Ceftriaxone antibiotic injection | 200 | $0 | $28 |
| Injection, garamycin, gentamicin, up to 80 mg | 156 | $2 | $4 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 151 | $36 | $108 |
| Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm | 123 | $583 | $1,417 |
| Instillation of anti-cancer drug into bladder | 87 | $64 | $216 |
| Removal of lymph nodes of both sides of pelvis using an endoscope | 86 | $268 | $1,523 |
| Surgical removal of prostate and surrounding lymph nodes using an endoscope | 86 | $926 | $3,397 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 67 | $298 | $637 |
| Office visit, established patient, complex (40-54 min) | 62 | $138 | $294 |
| Imaging of urinary tract following injection of a contrast agent | 59 | $19 | $51 |
| Drug injection, under skin or into muscle | 58 | $11 | $40 |
| Ultrasound scan of pelvic region through rectum | 52 | $104 | $250 |
| Hospital follow-up visit, moderate complexity | 47 | $63 | $148 |
| Dilation of urethra using an endoscope | 46 | $241 | $564 |
| Insertion of stent in ureter using an endoscope | 44 | $88 | $1,270 |
| Biopsy of prostate gland | 44 | $188 | $506 |
| Unclassified drugs | 43 | $741 | $1,645 |
| Placement of hormone pellet under skin | 34 | $68 | $196 |
| Initial hospital admission, moderate complexity | 29 | $103 | $283 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 28 | $230 | $726 |
| Hospital follow-up visit, low complexity | 27 | $40 | $86 |
| Destruction of prostate tissue using radiofrequency induced heated water vapor | 26 | $1,268 | $3,613 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 22 | $572 | $1,625 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 21 | $306 | $882 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 20 | $55 | $135 |
| Destruction and/or removal of large growth of bladder using an endoscope | 17 | $271 | $998 |
| Repair of bulging of rectum and bladder into vaginal wall | 17 | $376 | $2,940 |
| Surgical repair of vaginal defect using an endoscope | 17 | $795 | $2,417 |
| Telephone medical discussion with physician, 11-20 minutes | 15 | $70 | $158 |
| Simple surgical subtotal removal of prostate using laparoscope | 14 | $834 | $2,129 |
| Creation of sling around urethra in female to control leakage | 14 | $335 | $2,835 |
| Hospital follow-up visit, high complexity | 14 | $94 | $213 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 13 | $66 | $211 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 12 | $279 | $620 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 12 | $25 | $368 |
| Insertion of device into abdomen with pressure and urine flow rate study | 12 | $147 | $374 |
| Telephone medical discussion with physician, 5-10 minutes | 12 | $40 | $96 |
| Bladder ultrasound after voiding | 11 | $8 | $41 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (42%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Carey is a mixed practice specialist, with above-average Medicare volume (top 3% in FL), and high industry engagement (consulting-driven, top 14%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Carey experienced with injection, degarelix, 1 mg?
Does Dr. Carey receive payments from pharmaceutical companies?
How do Dr. Carey's costs compare to other urology physicians in Sarasota?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology